Dr Worth trained in medicine at the Universities of University of Cambridge and University of Oxford, qualifying in 1992. He completed further specialist training in London, including at the National Hospital for Neurology and Neurosurgery.

He also completed a PhD focused on the genetics of movement disorders, contributing to research in neurological disease and inherited neurological conditions.

Dr Worth was appointed Consultant Neurologist in Norwich in 2004. Since 2013, he has also been a Consultant Neurologist at Addenbrooke’s Hospital.

Since 2021, he has served as Clinical Director for Neurosciences at Addenbrooke’s Hospital, helping to lead and develop neurology and related specialist services.

Dr Worth has held several national leadership positions in neurology and Parkinson’s disease research. These include:

• Regional lead for the Parkinson’s Excellence Network (Eastern region)
• Specialty lead for research in neurological disorders and Parkinson’s disease within the Clinical Research Network (Eastern region)
• Member of Council of the Association of British Neurologists

He is also a member of the UK Parkinson’s Clinical Studies Group, where he helps identify gaps in knowledge and supports the development and prioritisation of new research into Parkinson’s disease and related neurological conditions.

Dr Worth is actively involved in medical education. He is the lead for neurology clinical teaching at the University of Cambridge.

In this role, he contributes to the training of medical students and future clinicians, helping to develop teaching programmes and support clinical learning in neurology.

Dr Worth has specialist expertise in neurology, with a focus on movement disorders such as Parkinson’s disease. His work combines clinical care, research, and education to improve understanding and treatment of neurological conditions.

Dr Worth is committed to providing high-quality, evidence-based neurological care. He focuses on accurate diagnosis, clear communication, and personalised treatment planning to support patients living with complex neurological conditions.

His approach brings together clinical expertise, research involvement, and teaching experience to deliver comprehensive and up-to-date neurological care.

 Clinical Interests

• Common neurological problems such as headache, sensory disorders, weakness, migraine and fits / epilepsy.
  
• Diagnosis and treatment of Parkinson’s and movement disorders such as ataxia, dystonia, progressive supranuclear palsy, multiple systems atrophy.
  
• Botulinum toxin for the treatment of dystonia